Friday, 20 November 201508:00 | ![Wansbeck General Hospital]() Free Workshop
Mass Spectrometry for Clinical Analysis
Nigel Brown, Consultant Clinical Scientist
| 10:00 | Coffee Break | |
Session 1: Investigation of Drugs & Drug Abuse using MS |
| | 10:30 |  | Keynote Presentation Role of Mass Spectrometry in Drug of Abuse Analysis: Human to Equine Dope Testing
Alka Beotra, Scientific Director & PT Coordinator, National Dope Testing Laboratory, India
The presentation would cover the development in the mass spectrometry use since the beginning of sports testing (1967) following separation by either gas or liquid chromatography. It will also discuss about the identification of various prohibited drugs with the use of mass spectrometry coupled with LC or GC. Further, it will mention about the application of isotope ratio mass spectrometer (IRMS) detector coupled with GC in dope testing. |
| 11:15 | Keynote: Studying Environmental Contamination in Soil and Water and its Impact on Society
Utpal Tatu, Professor, Indian Institute of Science Bangalore, India
| |
Session 2: Clinical Mass Spectrometry |
| | 12:00 | Investigation of the Mechanism of Binding of Anticancer Drugs to DNA using ESI-MS
David Harman, Lecturer and Mass Spectrometry Facility Manager , University of Western Sydney, Australia
This presentation will provide insights into the binding
mechanism of organometallic platinum based drugs within cancer cell DNA. It
will also discuss the measurement of degree of binding by ESI-QToF-MS that
helps in further designing of the next generation of anticancer therapeutics. | 12:50 | Development of an Assay for Plasma Ribavirin using HILIC-MS/MS
Nigel Brown, Consultant Clinical Scientist, Wansbeck General Hospital, United Kingdom
| 13:25 | Poster Viewing Session | 13:45 | Lunch Break | |
Session 3: MS in Diagnosis of Gliomas and Endocrine Disorders |
| | 14:55 |  | Keynote Presentation Role of LC-MS/MS Spectrometry in Diagnosis of Various Endocrine Disorders
Ravinder Singh, Director, Mayo Clinic, United States of America
|
| 15:55 | Quantitative and Functional Proteomics to Understand Glioma Pathogenesis and Identification of Biomarkers
Sanjeeva Srivastava, Associate Professor, Indian Institute of Technology Bombay, India
This talk will present the results from Studies of Gliomas by employing techniques like 2D-DIGE, Mass Spectrometry and Protein microarrays. It will discuss how the utilization of Quantitative and Functional Proteomics can provide mechanistic insight of glioma pathogenesis and identification of potential biomarkers. | 16:30 | End of Conference |
|
